View Item 

Show simple item record

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy
dc.contributor.authorXylinas, Evanguelosen_US
dc.contributor.authorRink, Michaelen_US
dc.contributor.authorMargulis, Vitalyen_US
dc.contributor.authorClozel, Thomasen_US
dc.contributor.authorLee, Richard K.en_US
dc.contributor.authorComploj, Evien_US
dc.contributor.authorNovara, Giacomoen_US
dc.contributor.authorRaman, Jay D.en_US
dc.contributor.authorLotan, Yairen_US
dc.contributor.authorWeizer, Alonen_US
dc.contributor.authorRoupret, Morganen_US
dc.contributor.authorPycha, Arminen_US
dc.contributor.authorScherr, Douglas S.en_US
dc.contributor.authorSeitz, Christianen_US
dc.contributor.authorFicarra, Vincenzoen_US
dc.contributor.authorTrinh, Quoc‐dienen_US
dc.contributor.authorKarakiewicz, Pierre I.en_US
dc.contributor.authorMontorsi, Francescoen_US
dc.contributor.authorZerbib, Marcen_US
dc.contributor.authorShariat, Shahrokh F.en_US
dc.date.accessioned2013-08-02T20:51:35Z
dc.date.available2014-10-06T19:17:44Zen_US
dc.date.issued2013-08en_US
dc.identifier.citationXylinas, Evanguelos; Rink, Michael; Margulis, Vitaly; Clozel, Thomas; Lee, Richard K.; Comploj, Evi; Novara, Giacomo; Raman, Jay D.; Lotan, Yair; Weizer, Alon; Roupret, Morgan; Pycha, Armin; Scherr, Douglas S.; Seitz, Christian; Ficarra, Vincenzo; Trinh, Quoc‐dien ; Karakiewicz, Pierre I.; Montorsi, Francesco; Zerbib, Marc; Shariat, Shahrokh F. (2013). "Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephroâ ureterectomy." BJU International (4): 453-461. <http://hdl.handle.net/2027.42/99046>en_US
dc.identifier.issn1464-4096en_US
dc.identifier.issn1464-410Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/99046
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherAmerican Joint Committee on Canceren_US
dc.subject.otherRenal Functionen_US
dc.subject.otherRadical Nephroureterectomyen_US
dc.subject.otherUpper Tract Urothelial Carcinomaen_US
dc.subject.otherChemotherapyen_US
dc.titleImpact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23464979en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/99046/1/bju11649.pdf
dc.identifier.doi10.1111/j.1464-410X.2012.11649.xen_US
dc.identifier.sourceBJU Internationalen_US
dc.identifier.citedreferenceHellenthal NJ, Shariat SF, Margulis V et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 2009; 182: 900 – 906en_US
dc.identifier.citedreferenceVassilakopoulou M, de la Motte Rouge T, Colin P et al. Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC): results from a large multicenter collaborative study. Cancer 2011; 117: 5500 – 5508en_US
dc.identifier.citedreferenceLane BR, Smith AK, Larson BT et al. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 2010; 116: 2967 – 2973en_US
dc.identifier.citedreferenceKaag MG, O'Malley RL, O'Malley P et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 2010; 58: 581 – 587en_US
dc.identifier.citedreferenceThompson RH, Boorjian SA, Lohse CM et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008; 179: 468 – 471en_US
dc.identifier.citedreferenceZigeuner R, Shariat SF, Margulis V et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 2010; 57: 575 – 581en_US
dc.identifier.citedreferenceNovara G, Matsumoto K, Kassouf W et al. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 2010; 57: 1064 – 1071en_US
dc.identifier.citedreferenceRemzi M, Haitel A, Margulis V et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients. BJU Int 2009; 103: 307 – 311en_US
dc.identifier.citedreferenceEpstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization / International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435 – 1448en_US
dc.identifier.citedreferenceGreene FL, Balch CM, Fleming ID et al. AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumors, 6th edn. Chicago, IL: American Joint Committee on Cancer, 2002en_US
dc.identifier.citedreferenceRouprêt M, Zigeuner R, Palou J et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584 – 594en_US
dc.identifier.citedreferenceMargulis V, Shariat SF, Matin SF et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224 – 1233en_US
dc.identifier.citedreferenceRoscigno M, Shariat SF, Margulis V et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 2009; 181: 2482 – 2489en_US
dc.identifier.citedreferenceAbouassaly R, Alibhai SM, Shah N, Timilshina N, Fleshner N, Finelli A. Troubling outcomes from population‐level analysis of surgery for upper tract urothelial carcinoma. Urology 2010; 76: 895 – 901en_US
dc.identifier.citedreferenceKwak C, Lee SE, Jeong IG, Ku JH. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 2006; 68: 53 – 57en_US
dc.identifier.citedreferencePatard JJ, Pantuck AJ, Crepel M et al. Morbidity and clinical outcome of nephron‐sparing surgery in relation to tumour size and indication. Eur Urol 2007; 52: 148 – 154en_US
dc.identifier.citedreferenceVan Poppel H, Da Pozzo L, Albrecht W et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron‐sparing surgery and radical nephrectomy for low‐stage renal cell carcinoma. Eur Urol 2011; 59: 543 – 552en_US
dc.identifier.citedreferenceCastro AF, Coresh J. CKD surveillance using laboratory data from the population‐based National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009; 53: 46 – 55en_US
dc.identifier.citedreferenceAdvanced Bladder Cancer (ABC) Meta‐analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta‐analysis of individual patient data advanced bladder cancer (ABC) meta‐analysis collaboration. Eur Urol 2005; 48: 189 – 199en_US
dc.identifier.citedreferenceAdvanced Bladder Cancer (ABC) Meta‐analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta‐analysis of individual patient data advanced bladder cancer (ABC) meta‐analysis collaboration. Eur Urol 2005; 48: 202 – 205en_US
dc.identifier.citedreferenceRajput MZ, Kamat AM, Clavell‐Hernandez J et al. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. Urology 2011; 78: 61 – 67en_US
dc.identifier.citedreferenceMatin SF, Margulis V, Kamat A et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinoma. Cancer 2010; 116: 3127 – 3134en_US
dc.identifier.citedreferenceChromecki TF, Bensalah K, Remzi M et al. Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol 2011; 8: 440 – 447en_US
dc.identifier.citedreferenceShikanov S, Clark MA, Raman JD et al. Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy. J Urol 2010; 184: 1867 – 1871en_US
dc.identifier.citedreferenceLevey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604 – 612en_US
dc.identifier.citedreferenceLevey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461 – 470en_US
dc.identifier.citedreferenceRink M, Fajkovic H, Cha EK et al. Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma. Eur Urol 2012; 61: 854 – 855en_US
dc.identifier.citedreferenceChromecki TF, Cha EK, Fajkovic H et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 2012; 61: 245 – 253en_US
dc.identifier.citedreferenceOuzzane A, Colin P, Xylinas E et al. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 2011; 60: 1258 – 1265en_US
dc.identifier.citedreferenceRaman JD, Ng CK, Scherr DS et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 2010; 57: 1072 – 1079en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bju11649.pdf
Size:
199.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.